PSS3 Topline Patient-Reported Outcome Results from a Multicenter, Open-Label, Phase 4 Study of Repository Corticotropin Injection in Patients with Refractory Severe Noninfectious Keratitis
Abstract
Authors
D. Wirta E. McLaurin G.W. Ousler III J. Liu O.R. Kacmaz J. Grieco